What is the recommended dosing regimen and indications for fomepizole in patients with methanol or ethylene glycol poisoning, including dose adjustments for renal or hepatic impairment?

Fomepizole Usage in Toxic Alcohol Poisoning

Fomepizole is the preferred first-line antidote for ethylene glycol and methanol poisoning, administered as a 15 mg/kg IV loading dose followed by 10 mg/kg every 12 hours for 4 doses, then 15 mg/kg every 12 hours until the toxic alcohol level is below 20 mg/dL and the patient is asymptomatic with normal pH. 1

Indications for Treatment

Begin fomepizole immediately when you suspect ethylene glycol or methanol ingestion based on:

• Patient history of ingestion
• Anion gap metabolic acidosis
• Increased osmolar gap
• Visual disturbances (methanol)
• Oxalate crystals in urine (ethylene glycol)
• OR documented serum ethylene glycol or methanol concentration >20 mg/dL 1

Do not wait for laboratory confirmation if clinical suspicion is high—early administration prevents toxic metabolite formation and reduces morbidity and mortality 2.

Standard Dosing Regimen

Initial Dosing (Without Hemodialysis)

• Loading dose: 15 mg/kg IV over 30 minutes
• Maintenance: 10 mg/kg IV every 12 hours × 4 doses
• Subsequent doses: 15 mg/kg IV every 12 hours thereafter
• Continue until toxic alcohol level <20 mg/dL AND patient is asymptomatic with normal pH 1

Dosing During Intermittent Hemodialysis

Fomepizole is dialyzable, requiring increased dosing frequency 1:

At hemodialysis initiation:

• If <6 hours since last dose: Do not give additional dose
• If ≥6 hours since last dose: Give next scheduled dose

During hemodialysis: Dose every 4 hours 1

At hemodialysis completion:

• <1 hour since last dose: No dose needed
• 1-3 hours since last dose: Give ½ of next scheduled dose

• 3 hours since last dose: Give full next scheduled dose

After hemodialysis: Resume 12-hour dosing interval 1

Dosing During Continuous Renal Replacement Therapy (CRRT)

Reduce maintenance dose by 50% during CRRT 3. Recent evidence demonstrates that half-dose fomepizole during CRRT maintains therapeutic plasma concentrations above the required 10 µmol/L threshold, with 98% of measured samples achieving adequate levels 3. This represents a significant cost-saving opportunity while maintaining efficacy.

When to Add Hemodialysis

The 2023 EXTRIP guidelines provide specific thresholds for adding extracorporeal treatment to fomepizole 4:

Strong recommendations for hemodialysis (with fomepizole):

• Coma due to ethylene glycol poisoning
• Seizures
• Acute kidney injury (KDIGO stage 2 or 3)
• Anion gap >27 mmol/L
• Glycolate concentration >12 mmol/L

Conditional recommendations for hemodialysis (with fomepizole):

• Ethylene glycol concentration >50 mmol/L (>310 mg/dL)
• Osmolar gap >50
• Anion gap 23-27 mmol/L
• Glycolate concentration 8-12 mmol/L
• Chronic kidney disease (eGFR <45 mL/min/1.73m²)

Critical distinction: When fomepizole is available, the threshold for dialysis is higher than with ethanol or no antidote. With ethanol, dialysis is recommended at lower concentrations (ethylene glycol 20-50 mmol/L) due to unpredictable ADH blockade and ethanol's adverse effects 4.

Renal and Hepatic Impairment

No dose adjustment is specified in the FDA label for renal or hepatic impairment 1. However:

• Patients with pre-existing chronic kidney disease (eGFR <45 mL/min/1.73m²) should be considered for hemodialysis at lower toxic alcohol thresholds 4
• Fomepizole elimination follows Michaelis-Menten kinetics with zero-order elimination rates of 13-17 μmol/L/h in poisoned patients, similar to healthy subjects 5
• The standard dosing regimen maintains therapeutic concentrations (>10 µmol/L) throughout treatment, with trough concentrations averaging 86-109 µmol/L—approximately 10 times the minimum therapeutic level 5

When to Stop Treatment

Discontinue fomepizole when ALL of the following are met 1:

• Ethylene glycol or methanol concentration undetectable or <20 mg/dL
• Patient is asymptomatic
• Normal pH

For patients on hemodialysis, stop dialysis when 4:

• Anion gap <18 mmol/L (strong recommendation)
• OR ethylene glycol concentration <4 mmol/L (25 mg/dL) (conditional recommendation)
• OR acid-base abnormalities corrected

Administration Details

• Dilute in ≥100 mL of 0.9% sodium chloride or 5% dextrose
• Infuse over 30 minutes
• Do NOT use polycarbonate syringes or needles—fomepizole interacts with polycarbonate, compromising syringe/needle integrity 1
• If solution solidifies at <25°C, liquefy by warming under water or in hand
• Use within 24 hours of dilution (no preservatives) 1

Pediatric Considerations

Use the same weight-based dosing regimen as adults 6. Pediatric data show:

• Fomepizole is well-tolerated with minimal adverse effects
• Ethylene glycol half-life during fomepizole therapy is 9-15 hours in children (faster than the 19.7 hours in adults)
• Many pediatric cases with high ethylene glycol concentrations (up to 3,500 mg/L) and severe acidosis (bicarbonate as low as 4 mEq/L) recovered without hemodialysis when treated early with fomepizole 6
• Two cases switched from ethanol to fomepizole due to ethanol adverse effects, with resolution of complications after the switch 6

Pregnancy

Fomepizole is FDA Category C 4. While used successfully in second and third trimesters without complications 4, consider lower thresholds for hemodialysis to minimize fetal exposure to both the antidote and toxic alcohols.

Advantages Over Ethanol

Fomepizole has clear superiority over ethanol 7, 2:

• Predictable pharmacokinetics (no concentration monitoring needed)
• Easy administration (intermittent dosing vs. continuous ethanol infusion)
• No CNS depression, dysphoria, or hypoglycemia
• No need for ICU-level monitoring
• Validated efficacy in preventing renal failure and neurological injury

The primary disadvantage is acquisition cost, though total treatment costs may be comparable when considering reduced ICU stay and monitoring requirements 4.

Common Pitfalls

• Starting too late: Begin immediately on clinical suspicion—don't wait for laboratory confirmation
• Underdosing during hemodialysis: Must increase to every 4 hours during intermittent HD
• Using polycarbonate equipment: This compromises drug delivery
• Stopping prematurely: Ensure toxic alcohol level <20 mg/dL AND normal pH AND asymptomatic
• Assuming dialysis is always needed: Early fomepizole administration may obviate hemodialysis in patients without severe acidosis, renal failure, or very high toxic alcohol levels 2, 8